Scholar Rock Holding Corporation
News
Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity
Business Wire Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases...\n more…
Candriam S.C.A. Acquires Shares of 744,443 Scholar Rock Holding Co. (NASDAQ:SRRK)
Ticker Report Candriam S.C.A. bought a new position in shares of Scholar Rock Holding Co. (NASDAQ:SRRK - Free Report) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 744,443...\n more…
Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer
Business Wire Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases...\n more…
Scholar Rock to Participate in Upcoming Investor Conferences
Business Wire Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases...\n more…
Scholar Rock Holding Co. (NASDAQ:SRRK) Receives Consensus Recommendation of "Buy" from Analysts
Ticker Report Shares of Scholar Rock Holding Co. (NASDAQ:SRRK - Get Free Report) have received a consensus rating of "Buy" from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. Six...\n more…
Caryn Parlavecchio Sells 1,451 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) Stock
Zolmax Scholar Rock Holding Co. (NASDAQ:SRRK - Get Free Report) insider Caryn Parlavecchio sold 1,451 shares of the business's stock in a transaction dated Friday, August 16th. The shares were sold at an...\n more…